Skip to main content
Recall Canary
Boston Scientific LUX-DX II Arrhythmia Detector
← Back to all recalls
MEDICAL DEVICE RECALLMODERATE

Boston Scientific LUX-DX II Arrhythmia Detector

Boston Scientific recalls LUX-DX II Arrhythmia Detector (M302) with LATITUDE DRAGON US Server (6460) over missing PVC Burden and Bradyarrhythmia monitoring.

What to do

Contact Boston Scientific or your healthcare provider to determine if your device is affected and to schedule a software update or device replacement. Do not attempt to modify the device yourself.

Recalled
Listed
Updated
Recall No.
Z-2048-2026
Agency
FDA
Firm
Boston Scientific Corporation
Recall ID
98679
Status
ONGOING

Why it was recalled

Boston Scientific is recalling the LUX-DX II Arrhythmia Detector and Alarm (Model M302) when used with the LATITUDE DRAGON US Server (Model 6460, Version 7.5) because for some patients upgraded from a LUX-Dx M301 device, the new ICM device is not collecting PVC Burden data (M302 and M312) or monitoring for Bradyarrhythmia and Pause (M312 only). Additionally, the LATITUDE Clarity programming screens show discrepant information, indicating monitoring is enabled in one location but not another.

Is mine affected?

Check the model, lot, or serial number on the device or its packaging. Yours is affected if it matches one below.

ProductRecall #UDI-DI
LUX-DX II, Arrythmia detector and alarm, Model M302, with SERVER SW LATITUDE DRAGON US, Model 6460, Version 7.5Z-2048-202600802526620713
LUX-Dx II Plus, Arrythmia detector and alarm, Model M312, with SERVER SW LATITUDE DRAGON EU (Europe), Model 6446, Version 7.5, or SERVER SW LATITUDE DRAGON AU (Australia/New Zealand), Model 6448, Version 7.5Z-2049-202600802526620706, 00802526623707, 00802526613821, 00802526613814

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Other recent recalls from Boston Scientific Corporation

All recalls from Boston Scientific Corporation

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-09-08 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification